SpringWorks Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

SpringWorks Therapeutics

02/05/2024 14:32

* SpringWorks Therapeutics Inc  SWTX.OQ  reported a
quarterly
adjusted loss of $1.18​​ per share for the quarter ended in
March, identical to the same quarter last year.  The mean
expectation of seven analysts for the quarter was for a loss of
$1.17 per share. Wall Street expected results to range from
$-1.35 to -85 cents per share.
    * Revenue was $21.01 million​; analysts expected $12.49
million. 
    * SpringWorks Therapeutics Inc's reported EPS for the
quarter was
a loss of $1.18​.
    * The company reported a quarterly loss of $87.39 million.
    * SpringWorks Therapeutics Inc shares had fallen by 4.8%
this
quarter and gained 28.3% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.7%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for SpringWorks
Therapeutics Inc is $63.26 
This summary was machine generated from LSEG data May 2 at 01:32
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -1.17          -1.18          Missed
 Dec. 31 2023      -1.24          -1.45          Missed
 Sep. 30 2023      -1.33          -1.27          Beat
 Jun. 30 2023      -1.26          -1.25          Beat